Cargando…

Matrix Metalloproteinases in Age-Related Macular Degeneration (AMD)

Age-related macular degeneration (AMD) is a complex, multifactorial and progressive retinal disease affecting millions of people worldwide. In developed countries, it is the leading cause of vision loss and legal blindness among the elderly. Although the pathogenesis of AMD is still barely understoo...

Descripción completa

Detalles Bibliográficos
Autores principales:	García-Onrubia, Luis, Valentín-Bravo, Fco. Javier, Coco-Martin, Rosa M., González-Sarmiento, Rogelio, Pastor, J. Carlos, Usategui-Martín, Ricardo, Pastor-Idoate, Salvador
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460693/ https://www.ncbi.nlm.nih.gov/pubmed/32824762 http://dx.doi.org/10.3390/ijms21165934

Ejemplares similares

Rho-Kinase Inhibitors for the Treatment of Refractory Diabetic Macular Oedema
por: Mateos-Olivares, Milagros, et al.
Publicado: (2021)

Meta-analysis of the rs243865 MMP-2 polymorphism and age-related macular degeneration risk
por: Usategui-Martín, Ricardo, et al.
Publicado: (2019)

Carotid dissection and central serous chorioretinopathy related to sarcoidosis-antiphospholipid syndrome: a case report
por: Valentín-Bravo, Francisco Javier, et al.
Publicado: (2022)

Cell Replacement Therapy for Retinal and Optic Nerve Diseases: Cell Sources, Clinical Trials and Challenges
por: Coco-Martin, Rosa M., et al.
Publicado: (2021)

Short-Wavelength Light–Blocking Filters and Oral Melatonin Administration in Patients With Retinitis Pigmentosa: Protocol for a Randomized Controlled Trial
por: Pastor-Idoate, Salvador, et al.
Publicado: (2023)

The role of lipocalin-2 in age-related macular degeneration (AMD)
por: Ghosh, Sayan, et al.
Publicado: (2020)

Age-Related Macular Degeneration (AMD): A View to the Future
por: Miller, Joan W., et al.
Publicado: (2021)

Potential Therapeutic Candidates for Age-Related Macular Degeneration (AMD)
por: Nashine, Sonali
Publicado: (2021)

Programmed Cell Death and Autophagy in an in vitro Model of Spontaneous Neuroretinal Degeneration
por: Puertas-Neyra, Kevin, et al.
Publicado: (2022)

Artificial Intelligence to Stratify Severity of Age-Related Macular Degeneration (AMD) and Predict Risk of Progression to Late AMD
por: Bhuiyan, Alauddin, et al.
Publicado: (2020)

Sex Differences in RANTES (CCL5) in Patients With Intermediate Age-Related Macular Degeneration (AMD) and Controls With no AMD
por: Fonteh, Cheryl N., et al.
Publicado: (2022)

Surgical Options for Optic Disc Pit Maculopathy: Perspectives and Controversies
por: Pastor-Idoate, Salvador, et al.
Publicado: (2020)

Serum levels of matrix metalloproteinase 2 and matrix metalloproteinase 9 elevated in polypoidal choroidal vasculopathy but not in age-related macular degeneration
por: Zeng, Renpan, et al.
Publicado: (2013)

Age-Related Macular Degeneration: New Paradigms for Treatment and Management of AMD
por: Hernández-Zimbrón, Luis Fernando, et al.
Publicado: (2018)

Brolucizumab and fluid in neovascular age-related macular degeneration (n-AMD)
por: Sharma, Ashish, et al.
Publicado: (2020)

Linking Adiponectin and Its Receptors to Age-Related Macular Degeneration (AMD)
por: Choubey, Mayank, et al.
Publicado: (2023)

Disturbed Matrix Metalloproteinase Pathway in Both Age-Related Macular Degeneration and Alzheimer's Disease
por: Hussain, Ali Aijaz, et al.
Publicado: (2017)

Initial non-responders to ranibizumab in the treatment of age-related macular degeneration (AMD)
por: Otsuji, Tsuyoshi, et al.
Publicado: (2013)

New and Innovative Treatments for Neovascular Age-Related Macular Degeneration (nAMD)
por: Patel, Prem, et al.
Publicado: (2021)

Effect of Humanin G (HNG) on inflammation in age-related macular degeneration (AMD)
por: Nashine, Sonali, et al.
Publicado: (2022)

Intravitreal allogeneic mesenchymal stem cells: a non-randomized phase II clinical trial for acute non-arteritic optic neuropathy
por: Pastor, Jose C., et al.
Publicado: (2023)

Current barriers to treatment for wet age-related macular degeneration (wAMD): findings from the wAMD patient and caregiver survey
por: Varano, Monica, et al.
Publicado: (2015)

Monitoring for neovascular age-related macular degeneration (AMD) reactivation at home: the MONARCH study
por: Ward, Elizabeth, et al.
Publicado: (2020)

Prevalence of Geographic Atrophy in Advanced Age-Related Macular Degeneration (AMD) in Daily Practice
por: Abdin, Alaa Din, et al.
Publicado: (2023)

Functional characterization of rs2229094 (T>C) polymorphism in the tumor necrosis factor locus and lymphotoxin alpha expression in human retina: the Retina 4 project
por: Pastor-Idoate, Salvador, et al.
Publicado: (2017)

Mechanistic Insight into Age-Related Macular Degeneration (AMD): Anatomy, Epidemiology, Genetics, Pathogenesis, Prevention, Implications, and Treatment Strategies to Pace AMD Management
por: Amini, Mohammad Amin, et al.
Publicado: (2023)

Matrix Metalloproteinase-1 and Matrix Metalloproteinase-9 in the Aqueous Humor of Diabetic Macular Edema Patients
por: Kwon, Jin-woo, et al.
Publicado: (2016)

What effects has the cataract surgery on the development and progression of Age-Related Macular Degeneration (AMD)?
por: Bockelbrink, Angelina, et al.
Publicado: (2006)

The effect of CFH polymorphisms on the response to the treatment of age-related macular degeneration (AMD) with intravitreal ranibizumab
por: Dikmetas, Ozlem, et al.
Publicado: (2013)

Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors
por: Pennington, Katie L., et al.
Publicado: (2016)

Role of Mitochondrial DNA Damage in ROS-Mediated Pathogenesis of Age-Related Macular Degeneration (AMD)
por: Kaarniranta, Kai, et al.
Publicado: (2019)

Inner blood-retina barrier involvement in dry age-related macular degeneration (AMD) pathology
por: Hudson, Natalie, et al.
Publicado: (2020)

Potential Role of Myeloid-Derived Suppressor Cells (MDSCs) in Age-Related Macular Degeneration (AMD)
por: Kauppinen, Anu, et al.
Publicado: (2020)

Ocular Therapeutics and Molecular Delivery Strategies for Neovascular Age-Related Macular Degeneration (nAMD)
por: Sarkar, Aira, et al.
Publicado: (2021)

Neovascular Age-Related Macular Degeneration (nAMD): A Review of Emerging Treatment Options
por: Tan, Colin S, et al.
Publicado: (2022)

Potential Sources and Roles of Adaptive Immunity in Age-Related Macular Degeneration: Shall We Rename AMD into Autoimmune Macular Disease?
por: Camelo, Serge
Publicado: (2014)

Evaluating Potential Therapies in a Mouse Model of Focal Retinal Degeneration with Age-related Macular Degeneration (AMD)-Like Lesions
por: Popp, Nicholas, et al.
Publicado: (2013)

Human Mesenchymal Stem Cell Secretome Exhibits a Neuroprotective Effect over In Vitro Retinal Photoreceptor Degeneration
por: Usategui-Martín, Ricardo, et al.
Publicado: (2020)

Role of antioxidant enzymes and small molecular weight antioxidants in the pathogenesis of age-related macular degeneration (AMD)
por: Tokarz, Paulina, et al.
Publicado: (2013)

Potential of Induced Pluripotent Stem Cells (iPSCs) for Treating Age-Related Macular Degeneration (AMD)
por: Fields, Mark, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_326n2ake2r6q7i73sl6jj5er2e